Descriptions
Autoinhibitory domains (AIDs)
Target domain |
194-373 (DH domain) |
Relief mechanism |
PTM |
Assay |
|
Target domain |
194-373 (DH domain) |
Relief mechanism |
PTM |
Assay |
|
Target domain |
194-373 (DH domain) |
Relief mechanism |
Partner binding, PTM |
Assay |
|
Accessory elements
No accessory elements
References
- Barreira M et al. (2014) "The C-terminal SH3 domain contributes to the intramolecular inhibition of Vav family proteins", Science signaling, 7, ra35
- Rapley J et al. (2008) "Crucial structural role for the PH and C1 domains of the Vav1 exchange factor", EMBO reports, 9, 655-61
- Aghazadeh B et al. (2000) "Structural basis for relief of autoinhibition of the Dbl homology domain of proto-oncogene Vav by tyrosine phosphorylation", Cell, 102, 625-33
- Yu B et al. (2010) "Structural and energetic mechanisms of cooperative autoinhibition and activation of Vav1", Cell, 140, 246-56
Autoinhibited structure

Activated structure

1 structures for P54100
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-P54100-F1 | Predicted | AlphaFoldDB |
No variants for P54100
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
No variants for P54100 |
No associated diseases with P54100
12 regional properties for P54100
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Dbl homology (DH) domain | 194 - 373 | IPR000219 |
domain | SH2 domain | 667 - 763 | IPR000980 |
conserved_site | Guanine-nucleotide dissociation stimulator, CDC24, conserved site | 322 - 347 | IPR001331 |
domain | SH3 domain | 590 - 658 | IPR001452-1 |
domain | SH3 domain | 780 - 840 | IPR001452-2 |
domain | Pleckstrin homology domain | 402 - 506 | IPR001849 |
domain | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain | 515 - 565 | IPR002219 |
domain | Calmodulin-regulated spectrin-associated protein-like, Calponin-homology domain | 19 - 102 | IPR022613 |
domain | VAV1 protein, second SH3 domain | 784 - 837 | IPR035729 |
domain | VAV1 protein, first SH3 domain | 594 - 656 | IPR035730 |
domain | VAV1, SH2 domain | 663 - 765 | IPR035879 |
domain | Vav, PH domain | 385 - 508 | IPR037832 |
1 GO annotations of cellular component
Name | Definition |
---|---|
cell-cell junction | A cell junction that forms a connection between two or more cells of an organism; excludes direct cytoplasmic intercellular bridges, such as ring canals in insects. |
4 GO annotations of molecular function
Name | Definition |
---|---|
guanyl-nucleotide exchange factor activity | Stimulates the exchange of GDP to GTP on a signaling GTPase, changing its conformation to its active form. Guanine nucleotide exchange factors (GEFs) act by stimulating the release of guanosine diphosphate (GDP) to allow binding of guanosine triphosphate (GTP), which is more abundant in the cell under normal cellular physiological conditions. |
metal ion binding | Binding to a metal ion. |
phosphorylation-dependent protein binding | Binding to a protein upon phosphorylation of the target protein. |
phosphotyrosine residue binding | Binding to a phosphorylated tyrosine residue within a protein. |
17 GO annotations of biological process
Name | Definition |
---|---|
cell development | The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate. |
G protein-coupled receptor signaling pathway | The series of molecular signals initiated by a ligand binding to its receptor, in which the activated receptor promotes the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, and ends with regulation of a downstream cellular process. The pathway can start from the plasma membrane, Golgi or nuclear membrane. |
immune response | Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
immune response-regulating cell surface receptor signaling pathway | The series of molecular signals initiated by an extracellular ligand binding to a receptor on the surface of the target cell capable of activating, perpetuating, or inhibiting an immune response. |
integrin-mediated signaling pathway | The series of molecular signals initiated by an extracellular ligand binding to an integrin on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
intracellular signal transduction | The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
neutrophil chemotaxis | The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding. |
phagocytosis | A vesicle-mediated transport process that results in the engulfment of external particulate material by phagocytes and their delivery to the lysosome. The particles are initially contained within phagocytic vacuoles (phagosomes), which then fuse with primary lysosomes to effect digestion of the particles. |
positive regulation of cell adhesion | Any process that activates or increases the frequency, rate or extent of cell adhesion. |
positive regulation of GTPase activity | Any process that activates or increases the activity of a GTPase. |
positive regulation of natural killer cell mediated cytotoxicity | Any process that activates or increases the frequency, rate or extent of natural killer cell mediated cytotoxicity. |
reactive oxygen species metabolic process | The chemical reactions and pathways involving a reactive oxygen species, any molecules or ions formed by the incomplete one-electron reduction of oxygen. They contribute to the microbicidal activity of phagocytes, regulation of signal transduction and gene expression, and the oxidative damage to biopolymers. |
regulation of cell size | Any process that modulates the size of a cell. |
regulation of GTPase activity | Any process that modulates the rate of GTP hydrolysis by a GTPase. |
small GTPase mediated signal transduction | The series of molecular signals in which a small monomeric GTPase relays a signal. |
T cell activation | The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific. |
T cell differentiation | The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex. |
9 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q08DN7 | VAV1 | Proto-oncogene vav | Bos taurus (Bovine) | SS |
Q9NHV9 | Vav | Protein vav | Drosophila melanogaster (Fruit fly) | SS |
Q9UKW4 | VAV3 | Guanine nucleotide exchange factor VAV3 | Homo sapiens (Human) | SS |
P52735 | VAV2 | Guanine nucleotide exchange factor VAV2 | Homo sapiens (Human) | SS |
P15498 | VAV1 | Proto-oncogene vav | Homo sapiens (Human) | EV SS |
Q9R0C8 | Vav3 | Guanine nucleotide exchange factor VAV3 | Mus musculus (Mouse) | SS |
Q60992 | Vav2 | Guanine nucleotide exchange factor VAV2 | Mus musculus (Mouse) | SS |
P27870 | Vav1 | Proto-oncogene vav | Mus musculus (Mouse) | EV |
Q45FX5 | vav-1 | Protein vav-1 | Caenorhabditis elegans | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MELWRQCTHW | LIQCRVLPPS | HRVTWEGAQV | CELAQALRDG | VLLCQLLNNL | LPHAINLREV |
70 | 80 | 90 | 100 | 110 | 120 |
NLRPQMSQFL | CLKNIRTFLS | TCCEKFGLKR | SELFEAFDLF | DVQDFGKVIY | TLSALSWTPI |
130 | 140 | 150 | 160 | 170 | 180 |
AQNKGIMPFP | TEDSALGDED | IYSGLSDQID | DTAEEDEDLY | DCVENEEAEG | DEIYEDLMRS |
190 | 200 | 210 | 220 | 230 | 240 |
ESVPTPPKMT | EYDKRCCCLR | EIQQTEEKYT | DTLGSIQQHF | MKPLQRFLKP | QDMETIFVNI |
250 | 260 | 270 | 280 | 290 | 300 |
EELLSVHTHF | LKELKDALSG | PGATMLYQVF | IKYKERFLVY | GRYCSQVESA | IKHLDQVATA |
310 | 320 | 330 | 340 | 350 | 360 |
REDVQMKLEE | CSQRANNGRF | TLRDLLMVPM | QRVLKYHLLL | QELVKHTQDT | TEKENLRLAL |
370 | 380 | 390 | 400 | 410 | 420 |
DAMRDLAQCV | NEVKRDNETL | RQITNFQLSI | ENLDQSLANY | GRPKIDGELK | ITSVERRSKT |
430 | 440 | 450 | 460 | 470 | 480 |
DRYAFLLDKA | LLICKRRGDS | YDLKASVNLH | SFQVRDDSSG | ERDNKKWSHM | FLLIEDQGAQ |
490 | 500 | 510 | 520 | 530 | 540 |
GYELFFKTRE | LKKKWMEQFE | MAISNIYPEN | ATANGHDFQM | FSFEETTSCK | ACQMLLRGTF |
550 | 560 | 570 | 580 | 590 | 600 |
YQGYRCYRCR | APAHKECLGR | VPPCGRQDFS | GTMKKDKLHR | RAQDKKRNEL | GLPKMEVCQE |
610 | 620 | 630 | 640 | 650 | 660 |
YYGIPPPPGA | FGPFLRLNPG | DIVELTKAEA | EHTWWEGRNT | ATNEVGWFPC | NRVRPYVHGP |
670 | 680 | 690 | 700 | 710 | 720 |
PQDLSVHLWY | AGPMERAGAE | GILTNRSDGT | YLVRQRVKDT | AEFAISIKYN | VEVKHIKIMT |
730 | 740 | 750 | 760 | 770 | 780 |
SEGLYRITEK | KAFRGLPELV | EFYQQNSLKD | CFKSLDTTLQ | FPYKEPERRA | INKPPVGSTK |
790 | 800 | 810 | 820 | 830 | 840 |
YFGTAKARYD | FCARDRSELS | LKEGDIIKIL | NKKGQQGWWR | GEIYGRIGWF | PSNYVEEDYS |
EYC |